🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed violative material and prohibited related hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of entering one group, a seller shared contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.